Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/2010
12/22/2010EP2263649A1 Pharmacological adjuvants based on coordination compounds of d-metals
12/22/2010EP2263465A1 Polyvalent conjugate vaccine for cancer
12/22/2010EP2262889A1 Dendritic cell precursor populations, dendritic cell populations derived therefrom and uses thereof
12/22/2010EP2262838A1 Agent for treating disease
12/22/2010EP2262836A1 Antibody against the csf-1 r
12/22/2010EP2262800A1 Novel pyrimidine-pyridine derivatives
12/22/2010EP2262799A1 Pyridine compounds
12/22/2010EP2262782A1 Novel aminomethyl benzene derivatives
12/22/2010EP2262775A1 (e)-n-(2-amino-phenyl)-3-{1-[4-(1-methyl-1h-pyrazol-4-yl)-benzenesulfonyl]-1h-pyrrol-3-yl}-acrylamide salts
12/22/2010EP2041100B1 Substituted 5- phenylamino- 1, 3, 4-oxadiaz0l-2-ylcarbonylamino-4-phenoxy-cyclohexane carboxylic acid as inhibitors of acetyl coenzyme a diacylglycerol acyltransferase
12/22/2010EP1838345B1 Saccharide conjugate vaccines
12/22/2010EP1651232B1 Compounds for inflammation and immune-related uses
12/22/2010CN1973681B Technological process of producing oat diet fiber and nutritious powder with oat bran
12/22/2010CN1928107B Methods for the production of 3-o-deactivated-4'-monophosphoryl lipid a (3d-mla)
12/22/2010CN1843222B Vinegar beverage and preparation method thereof
12/22/2010CN1812973B Indazole compounds useful as protein kinase inhibitors
12/22/2010CN1662242B Pharmaceutical compositions for the treatment of diseases related to neurotrophines
12/22/2010CN1547477B Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
12/22/2010CN1481390B Immunomodulatory peptides derived from heat shock proteins and uses thereof
12/22/2010CN101925606A Compounds comprising a cyclobutoxy group
12/22/2010CN101925383A Carboxamide compounds and their use as chemokine receptor agonists
12/22/2010CN101921772A Human antibodies that bind human IL-12 and methods for producing
12/22/2010CN101921346A Radial flow chromatography
12/22/2010CN101921325A Antigen capable of increasing CD4 + CD25 + Foxp3 + regulatory T cells and application thereof
12/22/2010CN101921279A Spirocyclic heterocyclic derivatives and methods of their use
12/22/2010CN101921267A Beta -lactamyl vasopressin Vla antagonists
12/22/2010CN101921236A 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
12/22/2010CN101920017A Composite for promoting glycyrrhetinic acid to realize percutaneous permeation
12/22/2010CN101919970A Asparagus based preparation for improving human immunity and preventing and treating cardiovascular and cerebrovascular diseases
12/22/2010CN101919961A Drug composition for treating cold and preparation method thereof
12/22/2010CN101919952A Medicine of alpha-ethyl linolenate matched with various natural plants for enhancing immunity
12/22/2010CN101919875A Enteromorpha mushroom polysaccharide compound, preparation method and application as health-care medicament thereof
12/22/2010CN101919853A Pharmaceutical composition, preparation method and application thereof
12/22/2010CN101919847A Use of HIF alpha stabilizers for enhancing erythropoiesis
12/22/2010CN101919844A Compound for controlling autoimmune disease and use thereof
12/22/2010CN101919832A Immunosuppressive agent of advanced higher fatty acid derivative and application thereof
12/22/2010CN101919801A Solid effervescent mixture for oral absorption
12/22/2010CN101642471B Pilose antler activity comprehensive processing and production technology
12/22/2010CN101380103B Dendrobium officinale extracturm and preparation method and use thereof
12/22/2010CN101353382B Extraction method of antioxidative active Cordyceps sinensis polysaccharide
12/22/2010CN101293889B Water-soluble arteannuin derivative and preparation method thereof
12/22/2010CN101284041B Compound radix astragali Chinese medicinal formulations with health-care function
12/22/2010CN101104648B Polyglucose and its extracting method and application
12/22/2010CN101040650B Health-care type ganoderma lucidum combined tea
12/21/2010US7855269 Down-regulating IL-19 comprising administering to an individual a polypeptide comprised of the extracellular domain of IL-20RA and the extracellular domain of IL-20RB.
12/21/2010US7855212 Pyridinyl acetonitriles
12/21/2010US7855203 Indazolyl-substituted pyrroline compounds as kinase inhibitors
12/21/2010US7855202 useful in the treatment respiratory system disorders, allergic diseases, inflammation, reperfusion injury, ischemia, atherosclerosis, hypertension, retinopathy, diabetes, gastrointestinal disorders and/or autoimmune diseases
12/21/2010US7854931 Immunizing compostion and method for inducing an immune response against the beta-secretase cleavage site of amyloid precursor protein
12/21/2010CA2543201C ((ir, 3s)-3-isopropyl-3-{ [3-(trifluoromethyl)-7, 8-dihydro-1, 6-naphthyridin-6 (5h)-yl] carbonyl} cyclopentyl) [(3s, 4s)-3-methoxytetrahydro-2h-pyran-4-yl] amine succinate salt, composition thereof, and its use in the treatment of inflammatory diseases
12/21/2010CA2444130C Adenine derivatives
12/21/2010CA2426654C 2,4,8-trisubstituted-8h-pyrido[2,3-d}pyrimidin-7-one compounds
12/21/2010CA2378396C Composition containing extracts of butyrospermum parkii and the use as medicament or dietary supplement
12/21/2010CA2351836C Glycosphingolipid
12/21/2010CA2214406C Use of penciclovir for the treatment of human herpes-virus-8
12/16/2010WO2010144874A2 Clusterin pharmaceuticals and treatment methods using the same
12/16/2010WO2010144602A2 Antigen-norovirus p-domain monomers and dimers, antigen-norovirus p-particle molecules, and methods for their making and use
12/16/2010WO2010144140A2 Egfr and par2 regulation of intestinal permeability
12/16/2010WO2010143171A1 Pharmaceutical composition contains parasite plant and saurauja nudiflora d. c.
12/16/2010WO2010143158A1 Oxazole and thiazole derivatives as alx receptor agonists
12/16/2010WO2010142997A1 Use of a serum composition to reduce the levels of tnf and/or vegf in mammals
12/16/2010WO2010142934A1 Indole derivatives as ligands of crth2 receptors
12/16/2010WO2010142752A1 Janus kinase inhibitor compounds and methods
12/16/2010WO2010142628A1 Pyrazole oxadiazole derivatives as s1p1 agonists
12/16/2010WO2010142504A1 Dry whole milk preparations containing probiotic micro-organisms
12/16/2010WO2010142030A1 Different serotypes of vesicular stomatitis virus as expression vectors for immunization regimens
12/16/2010WO2010142017A1 Administration of interferon for prophylaxis against or treatment of pathogenic infection
12/16/2010WO2010141985A1 Methods of treatment
12/16/2010WO2010116088A3 Quinazolinedione derivatives, preparation thereof and various therapeutic uses thereof
12/16/2010WO2010115751A3 Oxadiazole derivatives
12/16/2010WO2010099044A9 Treatment of immunosuppression-related disorders
12/16/2010WO2010093890A3 Processes for producing phenyl-6-(1-(phenyl)ureido)nicotinamides
12/16/2010WO2010075067A3 Methods for diagnosing and treating autoimmune disorders
12/16/2010WO2010046377A3 Immunoactivating conjugates comprising nanoparticles coated with peptides
12/16/2010WO2010013143A3 Methods for inhibiting mast cell activation and treating mast cell-dependent inflammatory diseases and disorders using lactobacillus
12/16/2010US20100317865 Enzyme and receptor modulation
12/16/2010US20100317722 NUCLEIC ACID SEQUENCES COMPRISING NF-kB BINDING SITE WITHIN O(6)-METHYLGUANINE-DNA-METHYLTRANSFERASE (MGMT) PROMOTER REGION AND USES THEREOF FOR THE TREATMENT OF CANCER AND IMMUNE-RELATED DISORDERS
12/16/2010US20100317720 Methods and Compositions for the Treatment of Intestinal Conditions
12/16/2010US20100317716 RNA INTERFERENCE MEDIATED INHIBITION OF TNF AND TNF RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
12/16/2010US20100317710 3-(3-indolyl) propionic acid calcium salt and method of making 3-(3-indolyl) propionic acid free acid therefrom
12/16/2010US20100317686 N-HETEROCYCLIC-6-HETEROCYCLIC-IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF
12/16/2010US20100317678 Hydroxamates as inhibitors of histone deacetylase
12/16/2010US20100317669 Novel substituted piperidyl-propane-thiols
12/16/2010US20100317659 Jak kinase modulating compounds and methods of use thereof
12/16/2010US20100317649 S1P Receptor Modulating Compounds and Use Thereof
12/16/2010US20100317634 Piperidyl-propane-thiol ccr3 modulators
12/16/2010US20100317606 Novel triterpenes for modulating gene expression and cell membrane, and as antiprotozoal agents
12/16/2010US20100317601 Casein Derived Peptides And Uses Thereof
12/16/2010US20100317596 Serum amyloid p derivatives and their preparation and use
12/16/2010US20100316727 Treatment of inflammatory disorders with ozone
12/16/2010US20100316724 Composition
12/16/2010US20100316715 Chitosan composition
12/16/2010US20100316714 Methods of treating disease with random copolymers
12/16/2010US20100316706 Carbocyclic and oxacarbocyclic fumaric acid oligomers
12/16/2010US20100316703 Rna interference mediating small rna molecules
12/16/2010US20100316695 Condensation products based on bicyclic or polycyclic aromatics or heteroaromatics
12/16/2010US20100316682 Biodegradable Hyaluronic Acid Derivative, Biodegradable Polymeric Micelle Composition and Pharmaceutical or Bioactive Composition
12/16/2010US20100316676 Bisphosphonate Compounds and Methods for Bone Resorption Diseases, Cancer, Bone Pain, Immune Disorders, and Infectious Diseases
12/16/2010US20100316674 Immunogenic compositions against tuberculosis
12/16/2010US20100316672 Vaccine
1 ... 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 ... 1172